InvestorsHub Logo
Followers 43
Posts 9124
Boards Moderated 0
Alias Born 01/06/2011

Re: jessellivermore post# 38969

Thursday, 11/20/2014 7:18:35 AM

Thursday, November 20, 2014 7:18:35 AM

Post# of 430702
You nailed it J.L. and the purchase was a pleasant surprise. The only reason I had my doubt's, was I did not think any institutions would be interested at this point in time and leaned towards the AHA meeting news. News events can be a driver of stock price, oncology stocks move during these types of meetings on fairly high volume for example. I think professionals will take a second look a Vascepa as a decent add in to Statin therapy.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News